Original researchMulticenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea
References (17)
Pharmacologic therapy for type 2 diabetes mellitus
Ann Intern Med
(1999)Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications
Diabetes Metab Res Rev
(2001)- et al.
National Pharmacy Cardiovascular Council treatment guidelines for the management of type 2 diabetes mellitus: Toward better patient outcomes and new roles for pharmacists
Pharmacotherapy
(2002) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
(1998)- et al.
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Stud (UKDPS) Group
Diabetes Med
(1998) - et al.
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group
JAMA
(1999) - et al.
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
BMJ
(2000) - et al.
Testing whether an identified treatment is best
Biometrics
(1989)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2003 Published by Elsevier Inc.